Protein kinase C beta type, Protein kinase C delta type, Protein kinase C epsilon type (PKCβI, PKCδ, PKCε)

The protein kinase C (PKC) family consists of a group of serine/threonine kinases that play key roles in signal transduction, controlling diverse processes such as cell proliferation, differentiation, survival, apoptosis, and cytoskeletal organization. PKC isoforms are classified by their requirement for calcium and diacylglycerol: PKC beta-I (PKCβI) is a conventional isoform activated by both calcium and DAG, while PKC delta (PKCδ) and PKC epsilon (PKCε) are novel isoforms requiring DAG but not calcium. PKCβI is implicated in immune function and diabetic complications. PKCδ is known for its dual role in both promoting apoptosis and supporting tumor growth depending on context, while PKCε is highly expressed in the heart, mediating cardioprotective effects and cell survival pathways. Aberrant PKC isoform activity is associated with cancer, cardiovascular and inflammatory diseases, and neurodegeneration. Isoform-specific targeting is of significant therapeutic interest, although pan-PKC modulators are limited by safety and selectivity concerns.

Other names

PKC beta-I (PKCβI)PKC delta (PKCδ)PKC epsilon (PKCε)Protein kinase C beta, Protein kinase C delta, Protein kinase C epsilonPRKCB (PKCβ gene), PRKCD (PKCδ gene), PRKCE (PKCε gene)nPKC-delta, nPKC-epsilon (for delta and epsilon subclasses)Protein kinase C isoforms

Inhibition of kinase activity (ATP-competitive inhibitors, e.g., enzastaurin, ruboxistaurin); Downregulation or modulation of phosphorylation status affecting signal transduction; Activation by phorbol esters mimicking endogenous diacylglycerol (DAG); Modulation of cell survival or apoptotic pathways via kinase activity regulation.